Expanding the indications for MRI in the diagnosis and treatment of breast cancer: What is best practice?

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    © 2015 The Authors. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing the extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper.
    Original languageEnglish
    Pages (from-to)47-53
    JournalJournal of Medical Radiation Sciences
    Volume62
    Issue number1
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Practice Guidelines
    Magnetic Resonance Imaging
    Breast Neoplasms
    Neoplasm Staging
    Breast
    Technology
    Therapeutics

    Cite this

    @article{23c1a9a48761448e92b5e1f3934376cd,
    title = "Expanding the indications for MRI in the diagnosis and treatment of breast cancer: What is best practice?",
    abstract = "{\circledC} 2015 The Authors. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing the extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper.",
    author = "Christobel Saunders and Donna Taylor",
    year = "2015",
    doi = "10.1002/jmrs.95",
    language = "English",
    volume = "62",
    pages = "47--53",
    journal = "Journal of Medical Radiation Sciences",
    issn = "1170-9758",
    publisher = "John Wiley & Sons",
    number = "1",

    }

    TY - JOUR

    T1 - Expanding the indications for MRI in the diagnosis and treatment of breast cancer: What is best practice?

    AU - Saunders, Christobel

    AU - Taylor, Donna

    PY - 2015

    Y1 - 2015

    N2 - © 2015 The Authors. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing the extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper.

    AB - © 2015 The Authors. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper. Breast magnetic resonance imaging (MRI) now has an accepted place in screening younger women at high risk of breast cancer, and is increasingly used in a number of other settings including assessment of response to neo-adjuvant therapy and local staging of cancer. Although the evidence for its general use in these settings is very limited, in highly selected patients, especially where discordance with conventional measurements occurs, MRI can have a place in assessing the extent of disease, both whether operable and how operable, and guiding surgery. These scenarios and future indications and alternative technologies are explored in this paper.

    U2 - 10.1002/jmrs.95

    DO - 10.1002/jmrs.95

    M3 - Article

    VL - 62

    SP - 47

    EP - 53

    JO - Journal of Medical Radiation Sciences

    JF - Journal of Medical Radiation Sciences

    SN - 1170-9758

    IS - 1

    ER -